Order Article Reprints

Samman WA, Selim SM, El Fayoumi HM, El-Sayed NM, Mehanna ET, Hazem RM. Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. Pharmaceuticals. 2023; 16(5):753. https://doi.org/10.3390/ph16050753

Samman, Waad A., Salma M. Selim, Hassan M. El Fayoumi, Norhan M. El-Sayed, Eman T. Mehanna, and Reem M. Hazem. 2023. "Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism" Pharmaceuticals 16, no. 5: 753. https://doi.org/10.3390/ph16050753

Samman, W. A., Selim, S. M., El Fayoumi, H. M., El-Sayed, N. M., Mehanna, E. T., & Hazem, R. M. (2023). Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. Pharmaceuticals, 16(5), 753. https://doi.org/10.3390/ph16050753